Stocks That Fell to 3-Year Lows in the Week of March 16

Celgene Corp. (CELG), CVS Health Corp. (CVS), Aflac Inc. (AFL), and WPP PLC (WPP) have declined to their respective three-year lows.

Author's Avatar
Mar 17, 2018
Article's Main Image

Celgene Corp. (CELG, Financial), CVS Health Corp. (CVS, Financial), Aflac Inc. (AFL, Financial), and WPP PLC (WPP, Financial) have declined to their three-year lows.

Celgene Corp. (CELG, Financial) declined to $89.61

The prices of Celgene Corp. (CELG, Financial) shares have declined to $89.61 on March 16, which is only 3.4% above the 3-year low of $86.55.

Celgene Corp. is an American biotechnology company that researches, develops, and commercializes treatments relating to cancer and inflammatory disorders. The company’s major product is Revlimid, which in combination with dexamethasone treats multiple myeloma in patients. Revlimid is sold through proprietary risk management distribution programs to ensure safe and appropriate use.

Celgene Corp. has a market cap of $67.4 billion; its shares were traded around $89.61 with a P/E ratio of 25.03 and P/S ratio of 5.56. Celgene Corp. had an annual average earnings growth of 21.40% over the past 5 years.

On March 6 Celgene Corp. announced that it has completed the acquisition of Juno Therapeutics Inc. The acquisition adds novel technology and advanced cellular manufacturing capabilities to Celgene Corp. and expands the company’s cellular immunotherapy portfolio. The company also gained full global rights to JCAR017, a potential CD-19 targeted CAR T therapy currently in trials for relapsed or refractory diffuse large B-cell lymphoma.

CVS Health Corp. (CVS, Financial) declined to $65.65

The prices of CVS Health Corp. (CVS, Financial) shares have declined to $65.65 on March 16, which is only 0.0% above the 3-year low of $65.65.

CVS Health Corp. is an American retail pharmacy and health care company that grew from the parent company Mark Steven Inc. The business began as a chain of health and beauty aid stores but within several years pharmacies were added. The company owns several subsidiaries, including CVS Pharmacy, MinuteClinic, Caremark Rx, Longs Drugs, Omnicare, and Navarro Discount Pharmacies. The company ranked seventh on the Fortunes 500 and eighteenth on the Fortune Global 500 in 2017.

CVS Health Corp. has a market cap of $66.6 billion; its shares were traded around $65.65 with a P/E ratio of 10.17 and P/S ratio of 0.37. The trailing 12-month dividend yield of CVS Health Corp. stocks is 3.06%. The forward dividend yield of CVS Health Corp. stocks is 3.04%. CVS Health Corp. had an annual average earnings growth of 10.90% over the past 10 years.

On Feb. 8 CVS Health Corp. reported fourth quarter results. Fourth quarter year-over-year net revenues increased 5.3% to $48.4 billion while GAAP diluted earnings per share were $3.22. Adjusted earnings per share were $1.92 excluding $1.5 billion income tax benefit resulting from tax reform. For the full year, net revenues increased 4.1% to $184.8 billion compared to last year and GAAP diluted earnings per share were $6.45.

Aflac Inc. (AFL, Financial) declined to $45.25

The prices of Aflac Inc. (AFL, Financial) shares have declined to $45.25 on March 16, which is only -13.6% above the 3-year low of $51.41.

Aflac Inc. is an American international insurance company and is the largest provider of supplemental insurance in the United States. The company underwrites a wide range of insurance policies and is best known for its payroll deduction insurance coverage. The company serves more than 50 million customers worldwide.

Aflac Inc. has a market cap of $35.26 billion; its shares were traded around $45.25 with a P/E ratio of 7.85 and P/S ratio of 1.67. The trailing 12-month dividend yield of Aflac Inc. stocks is 2.02%. The forward dividend yield of Aflac Inc. stocks is 2.31%. Aflac Inc. had an annual average earnings growth of 9.90% over the past 10 years.

On March 7 Aflac Inc. announced an agreement with Children’s Miracle Network Hospitals to sponsor several key CMN Hospital events throughout the year, including the second annual Children’s Hospital Week. The company will also sponsor the CMN Dance Marathon Leadership Conference in July and five Miracle Network Dance Marathon events held at universities across the country.

WPP PLC (WPP, Financial) declined to $81.14

The prices of WPP PLC (WPP, Financial) shares have declined to $81.14 on March 16, which is only 1.1% above the 3-year low of $80.26.

WPP PLC is a British international advertising and public relations company. The company owns a variety of advertising, public relations and market research networks, including IMRB, Millward Brown,Grey, and TNS. The company is a component of the FTSE 100 Index and has listings in both the NASDAQ and LSE.

WPP PLC has a market cap of $20.45 billion; its shares were traded around $81.14 with a P/E ratio of 8.19 and P/S ratio of 0.97. The trailing 12-month dividend yield of WPP PLC stocks is 4.75%. The forward dividend yield of WPP PLC stocks is 4.74%. WPP PLC had an annual average earnings growth of 7.90% over the past 10 years.

On March 1 WPP PLC announced 2017 preliminary results. Reported billings increased by 0.6% to £55.563 billion while reported revenue is up 6.1% at £15.265 billion. Constant currency revenue is up 1.6% while dividends per share are up 6% at 60.0p. Net debt increased £325 million to £4.483 billion.

Disclosure: I do not own stock in any of the companies mentioned in the article.